A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

Background Genetic abnormalities in cell cycle control are common in malignant melanoma. UCN-01 (7-hydroxystaurosporine) is an investigational agent that exhibits antitumor activity by perturbing the cancer cell cycle. A patient with advanced melanoma experienced a partial response in a phase I tria...

Full description

Bibliographic Details
Main Authors: Li, Tianhong, Christensen, Scott D., Frankel, Paul H., Margolin, Kim A., Agarwala, Sanjiv S., Luu, Thehang, Mack, Philip C., Lara, Primo N., Gandara, David R.
Format: Online
Language:English
Published: Springer US 2010
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277821/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277821/

Similar Items